Merit Medical Systems, Inc. (NASDAQ:MMSI) Given Average Recommendation of "Moderate Buy" by Brokerages

Key Points

• Analyst consensus is “Moderate Buy”: Eight of 11 covering firms rate Merit Medical Systems a buy, while three recommend holding the stock. The average 12-month price target is $100.30, above its reported opening price of $89.04.
• Merit exceeded quarterly expectations: The company reported $1.19 in EPS versus the $0.96 consensus estimate and revenue of $418.84 million versus expectations of $405.25 million. Revenue increased 9.5% year over year.
• Institutional ownership is very high: Hedge funds and other institutional investors own approximately 99.66% of the company’s outstanding shares, with several firms recently initiating or expanding positions.

Shares of Merit Medical Systems, Inc. (NASDAQ:MMSI - Get Free Report) have been assigned an average rating of "Moderate Buy" from the eleven ratings firms that are currently covering the stock, MarketBeat reports. Three equities research analysts have rated the stock with a hold rating and eight have given a buy rating to the company. The average 12-month price target among brokerages that have updated their coverage on the stock in the last year is $100.30.

Several research firms recently issued reports on MMSI. Compass Point set a $107.00 price objective on shares of Merit Medical Systems in a report on Monday, April 20th. Barrington Research set a $114.00 target price on shares of Merit Medical Systems in a report on Friday, July 31st. Needham & Company LLC boosted their target price on shares of Merit Medical Systems from $90.00 to $101.00 and gave the stock a "buy" rating in a research report on Friday, July 31st. BTIG Research upped their price target on shares of Merit Medical Systems from $100.00 to $105.00 and gave the company a "buy" rating in a report on Friday, July 31st. Finally, Raymond James Financial reaffirmed an "outperform" rating and issued a $100.00 price target on shares of Merit Medical Systems in a research report on Friday, July 31st.

Merit Medical Systems Stock Up 1.5%

MMSI opened at $89.04 on Friday. The business has a 50 day moving average price of $72.21 and a 200 day moving average price of $71.97. Merit Medical Systems has a twelve month low of $59.74 and a twelve month high of $94.75. The company has a debt-to-equity ratio of 0.44, a quick ratio of 2.79 and a current ratio of 4.20. The firm has a market cap of $5.32 billion, a P/E ratio of 36.79, a price-to-earnings-growth ratio of 2.21 and a beta of 0.49.

Merit Medical Systems (NASDAQ:MMSI - Get Free Report) last announced its earnings results on Thursday, July 30th. The medical instruments supplier reported $1.19 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.96 by $0.23. Merit Medical Systems had a return on equity of 13.75% and a net margin of 9.22%.The firm had revenue of $418.84 million during the quarter, compared to analysts' expectations of $405.25 million. During the same quarter in the prior year, the business earned $1.01 earnings per share. The company's revenue was up 9.5% on a year-over-year basis. Merit Medical Systems has set its FY 2026 guidance at 4.250-4.350 EPS. Research analysts forecast that Merit Medical Systems will post 3.81 EPS for the current year.

Institutional Trading of Merit Medical Systems

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Los Angeles Capital Management LLC acquired a new position in shares of Merit Medical Systems during the fourth quarter worth approximately $25,000. Maseco LLP acquired a new stake in shares of Merit Medical Systems in the fourth quarter worth $26,000. Torren Management LLC acquired a new stake in shares of Merit Medical Systems in the fourth quarter worth $38,000. Covestor Ltd increased its position in Merit Medical Systems by 252.6% during the fourth quarter. Covestor Ltd now owns 469 shares of the medical instruments supplier's stock worth $41,000 after acquiring an additional 336 shares during the period. Finally, Danske Bank A S bought a new position in Merit Medical Systems during the third quarter worth $42,000. Institutional investors and hedge funds own 99.66% of the company's stock.

Merit Medical Systems Company Profile

Merit Medical Systems, Inc is a global manufacturer and marketer of a broad range of medical devices used in diagnostic and interventional procedures. The company's product portfolio encompasses vascular access, drainage, embolotherapy, and interventional oncology devices, as well as radiofrequency ablation systems and hemostasis solutions. These products serve physicians and hospitals in critical care settings and support minimally invasive treatment options across multiple specialties, including cardiology, radiology, oncology, neurology and endoscopy.

Founded in 1987 by Fred Lampropoulos, Merit Medical Systems has grown through both organic development and targeted acquisitions to expand its technology offerings and geographic reach.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source